Harm Ledger · provisional · Medicine & Health

Novo taps Anthropic's Claude AI for drug discovery - pharmaphorum

Novo taps Anthropic's Claude AI for drug discovery pharmaphorum

17 Sep 2026Tier 1 Limited HarmMethodology 0.2

Current score

−0.02

1 base · Limited Harm (tier 1 of 5, 1 pts)

× 0.7500 attribution · Critical contribution

× 0.1500 evidence · Developer announcement

× 0.4000 realization · Demonstrated

× 0.5000 durability · Medium-term

Event-level product before credit split: 0.02

Auto-published from news ingest as a provisional placeholder. Score is conservative until a named release is identified and the record is rescored.

What happened

Novo taps Anthropic's Claude AI for drug discovery pharmaphorum

Version unspecified

−0.02

Unspecified system mentioned or implied by a news item. Remap to a named release when identified.

News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.

Attribution 0.7500 · Credit share 100% · Unknown

Novo taps Anthropic's Claude AI for drug discovery - pharmaphorum
outcome · supported

primary sources